Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

Proteomics: A New Discipline in Cancer

Proteomics: A New Discipline in Cancer

Leading causes of cancer deaths include lack of early-detection systems and undiscovered biomarkers. Alongside recent promising genetic advances, we are encountering a discipline that may greatly facilitate early diagnosis: “Proteomics”

Proteomics studies proteins and their relationships

DNA is the cell's main controller. Each section is called a gene , and genetic information enables production of proteins carrying out vital bodily processes.

For a concrete example, imagine proteins as a meal: genes provide the recipe for producing them.

Protein research has increased recently. Our body has 22 thousand genes corresponding to more than 500.000protein types. Proteins are more complex than genes. Their modifications, relationships with different pathways, functions at different locations and responses to diseases or stimuli make them vitally important. High gene activity also does not necessarily mean abundant production of its protein. Cancer can therefore be considered a proteomic disease.

Besides genomic contributions, errors in protein modifications after production play an important role in cancer. Detecting tumor-specific proteins therefore offers great hope for early diagnosis.

The discipline examining proteins' cancer roles is called clinical proteomics is the name of this scientific discipline. The aim of clinical proteomics is to identify the proteins involved in cancer development and reveal the pathways in which they participate. To this end, researchers are studying the following topics;

  1. In cancer, drug resistanceand discovering the proteins causing it
  2. Cancer-causing rare proteins detected from small blood or urine samples
  3. Tumor dormancyand identifying its proteins to determine when and how tumors enter dormancy
  4. Identifying when and how mutated cancer proteins are damaged, to develop targeted treatments as therapies.

In conclusion, proteomics opens new horizons in cancer research. It has gained great importance because it targets proteins, which play more functional roles in cancer than genes.

Sources

1. Abdelkrim Khadir and Ali Tiss
Proteomics Approaches towards Early Detection and Diagnosis of Cancer
J Carcinogene Mutagene 2013, S14

2. Pothur R. Srinivas
Proteomics for Cancer Biomarker Discovery
Clinical Chemistry Aug 2002, 48 (8) 1160-1169;

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

Proteomics: A New Discipline in Cancer

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy